We are live on ! Find out more
AGL icon

Agilon Health

201 hedge funds and large institutions have $2.98B invested in Agilon Health in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 75 increasing their positions, 52 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more call options, than puts

Call options by funds: $22M | Put options by funds: $13.1M

44% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 52

13% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 40

10% more capital invested

Capital invested by funds: $2.71B → $2.98B (+$269M)

2% more funds holding

Funds holding: 198201 (+3)

0.1% more ownership

Funds ownership: 4.34%4.43% (+0.1%)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
201
Holders Change
+3
Holders Change %
+1.52%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
45
Increased
75
Reduced
52
Closed
40
Calls
$22M
Puts
$13.1M
Net Calls
+$8.95M
Net Calls Change
+$8.92M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
51
Bridgewater Associates
Connecticut
$1.55M -$251K -1,763 -16%
William Blair & Company
52
William Blair & Company
Illinois
$1.51M -$62.8K -441 -5%
Nomura Holdings
53
Nomura Holdings
Japan
$1.39M +$694K +4,870 +134%
JFG
54
Jefferies Financial Group
New York
$1.39M -$224K -1,574 -16%
Dimensional Fund Advisors
55
Dimensional Fund Advisors
Texas
$1.33M -$2.01M -14,078 -63%
ECU
56
Eisler Capital (US)
New York
$1.27M +$1.1M +7,741 New
Walleye Capital
57
Walleye Capital
New York
$1.23M +$1.05M +7,389 +5,027%
TI
58
Trexquant Investment
Connecticut
$1.2M +$1.05M +7,370 New
D.E. Shaw & Co
59
D.E. Shaw & Co
New York
$1.19M +$938K +6,587 +980%
CM
60
Caption Management
Oklahoma
$1.12M -$1.01M -7,088 -51%
CF
61
Corebridge Financial
Texas
$1.09M +$946K +6,639 New
NICM
62
Neo Ivy Capital Management
New York
$1.01M +$877K +6,153 New
New York State Common Retirement Fund
63
New York State Common Retirement Fund
New York
$982K -$239K -1,677 -22%
Wells Fargo
64
Wells Fargo
California
$938K +$582K +4,084 +247%
SEC
65
Seven Eight Capital
New York
$927K -$681K -4,780 -46%
Ensign Peak Advisors
66
Ensign Peak Advisors
Utah
$922K +$244K +1,710 +44%
AC
67
AXQ Capital
New Jersey
$916K -$233K -1,633 -23%
Janus Henderson Group
68
Janus Henderson Group
United Kingdom
$898K -$8.83K -62 -1%
Verition Fund Management
69
Verition Fund Management
Connecticut
$830K -$905K -6,350 -56%
Envestnet Asset Management
70
Envestnet Asset Management
Illinois
$725K +$417K +2,924 +194%
State of Wisconsin Investment Board
71
State of Wisconsin Investment Board
Wisconsin
$712K -$67.4K -473 -10%
Mariner
72
Mariner
Kansas
$689K -$17.1K -120 -3%
VOYA Investment Management
73
VOYA Investment Management
Georgia
$675K -$57.3K -402 -9%
AG
74
Algert Global
California
$670K +$466K +3,274 +398%
SAM
75
Simplify Asset Management
Nevada
$659K +$574K +4,029 New

AGL Hedge Fund Activity: Q2 2024 in Review

201 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2024, worth a combined $2.98B — up 9.9% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AGL positions and 40 closed out — a net gain of 5 holders — while 75 added to existing stakes and 52 trimmed.

The largest buyer was BlackRock, adding an estimated $52.6M. The largest seller was Capital International Investors, cutting an estimated $44.2M.

  • 201 institutional investors held Agilon Health (AGL) as of Q2 2024, up from 198 in Q1 2024.
  • Funds reported $2.98B of Agilon Health stock for Q2 2024, up 9.9% quarter-over-quarter.
  • 45 funds opened new Agilon Health positions in Q2 2024 and 40 closed out, a net change of +5 holders.
  • The largest Agilon Health buyer in Q2 2024 was BlackRock, an estimated $52.6M added.
  • The largest Agilon Health seller in Q2 2024 was Capital International Investors, an estimated $44.2M sold.

Based on aggregated 13F filings for Q2 2024.